Insulin resistance in psoriasis: beyond comorbidity?
Insulin resistance is increasingly recognised as being closely linked to psoriasis severity and treatment response, rather than simply representing an associated metabolic comorbidity. Emerging evidence for GLP-1 receptor agonists further supports the potential for targeting metabolic dysfunction as part of psoriasis management.
Authors
- Anne‐Marie Tobin (ORCID: https://orcid.org/0000-0003-2730-9561)
- Rosalind Hughes (ORCID: https://orcid.org/0000-0001-6533-0412)
- Maeve Herlihy (ORCID: https://orcid.org/0000-0002-2160-4829)
- Emma Carroll
- Maria Visan
- Brian Kirby
Institutions
- University College Dublin (IE)
- Carol Davila University of Medicine and Pharmacy (RO)
- Trinity College Dublin (IE)
- Tallaght University Hospital (IE)
- Emergency University (US)
- St. Vincent's University Hospital (IE)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1093/bjd/ljag383
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00